Literature DB >> 16338626

Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.

Rita Maccario, Antonia Moretta, Angela Cometa, Daniela Montagna, Patrizia Comoli, Franco Locatelli, Marina Podestà, Francesco Frassoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16338626     DOI： 10.1016/j.bbmt.2005.08.039

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  16 in total

1.  Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.

Authors:  Antoinette Flemming; Katharina Schallmoser; Dirk Strunk; Meaghan Stolk; Hans-Dieter Volk; Martina Seifert
Journal:  J Clin Immunol       Date:  2011-09-02       Impact factor: 8.317

Review 2.  Rationale for the potential use of mesenchymal stromal cells in liver transplantation.

Authors:  Morgan Vandermeulen; Céline Grégoire; Alexandra Briquet; Chantal Lechanteur; Yves Beguin; Olivier Detry
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.

Authors:  Vasileios Karantalis; Viky Y Suncion-Loescher; Luiza Bagno; Samuel Golpanian; Ariel Wolf; Cristina Sanina; Courtney Premer; Anthony J Kanelidis; Frederic McCall; Bo Wang; Wayne Balkan; Jose Rodriguez; Marcos Rosado; Azorides Morales; Konstantinos Hatzistergos; Makoto Natsumeda; Irene Margitich; Ivonne Hernandez Schulman; Samirah A Gomes; Muzammil Mushtaq; Darcy L DiFede; Joel E Fishman; Pradip Pattany; Juan Pablo Zambrano; Alan W Heldman; Joshua M Hare
Journal:  J Am Coll Cardiol       Date:  2015-11-03       Impact factor: 24.094

4.  The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects.

Authors:  Václav Vaněček; Karel Klíma; Aleš Kohout; René Foltán; Ondřej Jiroušek; Jiří Šedý; Jan Štulík; Eva Syková; Pavla Jendelová
Journal:  Eur Spine J       Date:  2013-09-07       Impact factor: 3.134

Review 5.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

6.  Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.

Authors:  Yang-Hee Kim; Yu-Mee Wee; Monica-Y Choi; Dong-Gyun Lim; Song-Cheol Kim; Duck-Jong Han
Journal:  Mol Med       Date:  2011-02-25       Impact factor: 6.354

Review 7.  Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing.

Authors:  Alexander R Badiavas; Evangelos V Badiavas
Journal:  Expert Opin Biol Ther       Date:  2011-08-20       Impact factor: 4.388

8.  Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.

Authors:  J M Brown; K Nemeth; N M Kushnir-Sukhov; D D Metcalfe; E Mezey
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

Review 9.  Cyclosporin in cell therapy for cardiac regeneration.

Authors:  S J Jansen Of Lorkeers; E Hart; X L Tang; M E D Chamuleau; P A Doevendans; R Bolli; S A J Chamuleau
Journal:  J Cardiovasc Transl Res       Date:  2014-05-16       Impact factor: 4.132

10.  Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.

Authors:  Sandhya Kharbanda; Angela R Smith; Stephanie K Hutchinson; David H McKenna; James B Ball; Lawrence S Lamb; Rajni Agarwal; Kenneth I Weinberg; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-24       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.